Related Experiment Video
Updated: Mar 9, 2026

Preparation Of Gushukang GSK Granules for In Vivo and In Vitro Experiments
Published on: May 9, 2019
Targeted activation of AMPK by GSK621 ameliorates H2O2-induced damages in osteoblasts
Weidong Liu1, Li Mao2, Feng Ji1
1Department of Orthopedics, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China.
Abstract:
GSK621 is a novel AMP-activated protein kinase (AMPK) activator. This study tested its potential cytoprotective effect in hydrogen peroxide (H2O2)-treated osteoblasts. In cultured MC3T3-E1 osteoblastic cells and primary murine osteoblasts, GSK621 significantly attenuated H2O2-induced cell death and apoptosis. AMPK activation was required for GSK621-induced osteoblast cytoprotection. Inhibition of AMPK, by AMPKα1 T172A mutation or shRNA silence, almost completely blocked GSK621-induced osteoblast cytoprotection. Reversely, introduction of a constitutively-active AMPKα1 (T172D) alleviated H2O2 injuries in MC3T3-E1 cells. Further, GSK621 increased nicotinamide adenine dinucleotide phosphate (NADPH) content in osteoblasts to inhibit H2O2-induced reactive oxygen species (ROS) production. Meanwhile, GSK621 activated cytoprotective autophagy in the osteoblasts. On the other hand, pharmacological inhibition of autophagy alleviated GSK621-mediated osteoblast cytoprotection against H2O2. These results suggest that targeted activation of AMPK by GSK621 ameliorates H2O2-induced osteoblast cell injuries.
Insights
GSK621 protects osteoblasts from hydrogen peroxide damage by activating AMP-activated protein kinase (AMPK). This novel activator reduces cell death and apoptosis, highlighting its therapeutic potential.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Osteoblasts are crucial for bone health.
- Oxidative stress, induced by hydrogen peroxide (H2O2), can cause osteoblast injury.
- AMP-activated protein kinase (AMPK) is a key regulator of cellular energy metabolism and survival.
Purpose of the Study:
- To investigate the cytoprotective effects of GSK621, a novel AMPK activator, in H2O2-treated osteoblasts.
- To elucidate the role of AMPK activation in GSK621-mediated cytoprotection.
- To explore the mechanisms underlying GSK621's protective effects, including its impact on reactive oxygen species (ROS) and autophagy.
Main Methods:
- Utilized cultured MC3T3-E1 osteoblastic cells and primary murine osteoblasts.
- Administered H2O2 to induce oxidative stress.
- Assessed cell viability and apoptosis.
- Manipulated AMPK activity using genetic (mutations, shRNA) and pharmacological approaches.
- Measured nicotinamide adenine dinucleotide phosphate (NADPH) and ROS levels.
- Investigated the role of autophagy through pharmacological inhibition.
Main Results:
- GSK621 significantly reduced H2O2-induced cell death and apoptosis in osteoblasts.
- AMPK activation was essential for GSK621's cytoprotective effects; inhibition of AMPK blocked protection.
- Overexpression of a constitutively active AMPK mutant alleviated H2O2-induced injury.
- GSK621 increased intracellular NADPH levels, leading to decreased H2O2-induced ROS production.
- GSK621 activated cytoprotective autophagy, which was necessary for its protective effects.
Conclusions:
- Targeted activation of AMPK by GSK621 effectively ameliorates H2O2-induced injury in osteoblasts.
- GSK621 exerts cytoprotection by enhancing NADPH levels to reduce ROS and activating autophagy.
- GSK621 represents a promising therapeutic agent for conditions involving osteoblast oxidative stress.
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
PI3K/mTOR/AKT Signaling Pathway